CME Group Inc. (NASDAQ:CME) Shares Sold by Quintet Private Bank Europe S.A.

Quintet Private Bank Europe S.A. cut its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 4.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,600 shares of the financial services provider's stock after selling 1,356 shares during the period. Quintet Private Bank Europe S.A.'s holdings in CME Group were worth $8,648,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of CME. New Age Alpha Advisors LLC raised its position in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after buying an additional 43 shares during the last quarter. Knuff & Co LLC purchased a new position in CME Group during the 4th quarter worth approximately $33,000. Banque Transatlantique SA purchased a new position in CME Group during the 4th quarter worth approximately $35,000. Whipplewood Advisors LLC purchased a new position in CME Group during the 4th quarter worth approximately $37,000. Finally, United Community Bank purchased a new position in CME Group during the 4th quarter worth approximately $37,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other CME Group news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $272.56, for a total transaction of $817,680.00. Following the sale, the director now owns 5,400 shares of the company's stock, valued at $1,471,824. The trade was a 35.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Larry G. Gerdes sold 2,000 shares of CME Group stock in a transaction on Thursday, April 24th. The stock was sold at an average price of $264.10, for a total transaction of $528,200.00. Following the sale, the director now directly owns 38,651 shares in the company, valued at approximately $10,207,729.10. This trade represents a 4.92% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 13,400 shares of company stock valued at $3,680,610. 0.30% of the stock is owned by corporate insiders.

CME Group Price Performance

NASDAQ CME traded down $1.46 on Friday, hitting $269.50. The company had a trading volume of 1,576,352 shares, compared to its average volume of 2,198,614. The company has a market capitalization of $97.12 billion, a PE ratio of 27.87, a PEG ratio of 6.76 and a beta of 0.45. The company's fifty day moving average price is $272.44 and its 200-day moving average price is $254.03. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.50 EPS. As a group, analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.86%. The ex-dividend date is Monday, June 9th. CME Group's payout ratio is presently 50.30%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. JPMorgan Chase & Co. reduced their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Raymond James raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price for the company in a report on Monday, March 10th. UBS Group lifted their target price on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a report on Friday, April 25th. Piper Sandler lifted their target price on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Finally, Keefe, Bruyette & Woods lifted their target price on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a report on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, CME Group currently has a consensus rating of "Hold" and an average target price of $258.20.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.